152 related articles for article (PubMed ID: 37172287)
1. Chemoenzymatic Synthesis of Novel Cytotoxic Epoxyketones Using the Eponemycin Biosynthetic Enzyme EpnF.
Corless BC; Geißen R; Prescott NA; David Y; Scheinberg DA; Tan DS
ACS Chem Biol; 2023 Jun; 18(6):1360-1367. PubMed ID: 37172287
[TBL] [Abstract][Full Text] [Related]
2. Epoxomicin and Eponemycin Biosynthesis Involves gem-Dimethylation and an Acyl-CoA Dehydrogenase-Like Enzyme.
Zettler J; Zubeil F; Kulik A; Grond S; Kaysser L
Chembiochem; 2016 May; 17(9):792-8. PubMed ID: 26789439
[TBL] [Abstract][Full Text] [Related]
3. Identifying the Minimal Enzymes Required for Biosynthesis of Epoxyketone Proteasome Inhibitors.
Liu J; Zhu X; Zhang W
Chembiochem; 2015 Dec; 16(18):2585-9. PubMed ID: 26477320
[TBL] [Abstract][Full Text] [Related]
4. Genetic basis for the biosynthesis of the pharmaceutically important class of epoxyketone proteasome inhibitors.
Schorn M; Zettler J; Noel JP; Dorrestein PC; Moore BS; Kaysser L
ACS Chem Biol; 2014 Jan; 9(1):301-9. PubMed ID: 24168704
[TBL] [Abstract][Full Text] [Related]
5. Development of a new class of proteasome inhibitors with an epoxyketone warhead: Rational hybridization of non-peptidic belactosin derivatives and peptide epoxyketones.
Kawamura S; Unno Y; Asai A; Arisawa M; Shuto S
Bioorg Med Chem; 2014 Jun; 22(12):3091-5. PubMed ID: 24814885
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Novel Epoxyketone Peptides as Lipase Inhibitors.
Almaliti J; Alzweiri M; Alhindy M; Al-Helo T; Daoud I; Deknash R; Naman CB; Abu-Irmaileh B; Bustanji Y; Hamad I
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408660
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of proteasome inhibitors.
Bo Kim K; Fonseca FN; Crews CM
Methods Enzymol; 2005; 399():585-609. PubMed ID: 16338383
[TBL] [Abstract][Full Text] [Related]
8. A Flavin-Dependent Decarboxylase-Dehydrogenase-Monooxygenase Assembles the Warhead of α,β-Epoxyketone Proteasome Inhibitors.
Zabala D; Cartwright JW; Roberts DM; Law BJ; Song L; Samborskyy M; Leadlay PF; Micklefield J; Challis GL
J Am Chem Soc; 2016 Apr; 138(13):4342-5. PubMed ID: 26999044
[TBL] [Abstract][Full Text] [Related]
9. Exploring dual electrophiles in peptide-based proteasome inhibitors: carbonyls and epoxides.
Xin BT; de Bruin G; Verdoes M; Filippov DV; van der Marel GA; Overkleeft HS
Org Biomol Chem; 2014 Aug; 12(30):5710-8. PubMed ID: 24968066
[TBL] [Abstract][Full Text] [Related]
10. Systematic Analyses of Substrate Preferences of 20S Proteasomes Using Peptidic Epoxyketone Inhibitors.
Huber EM; de Bruin G; Heinemeyer W; Paniagua Soriano G; Overkleeft HS; Groll M
J Am Chem Soc; 2015 Jun; 137(24):7835-42. PubMed ID: 26020686
[TBL] [Abstract][Full Text] [Related]
11. Macyranones: Structure, Biosynthesis, and Binding Mode of an Unprecedented Epoxyketone that Targets the 20S Proteasome.
Keller L; Plaza A; Dubiella C; Groll M; Kaiser M; Müller R
J Am Chem Soc; 2015 Jul; 137(25):8121-30. PubMed ID: 26050527
[TBL] [Abstract][Full Text] [Related]
12. Production of Epoxyketone Peptide-Based Proteasome Inhibitors by
Domingues Vieira B; Niero H; de Felício R; Giolo Alves LF; Freitas Bazzano C; Sigrist R; Costa Furtado L; Felix Persinoti G; Veras Costa-Lotufo L; Barretto Barbosa Trivella D
Front Microbiol; 2022; 13():786008. PubMed ID: 35401454
[No Abstract] [Full Text] [Related]
13. Parallelized gene cluster editing illuminates mechanisms of epoxyketone proteasome inhibitor biosynthesis.
Huang C; Zabala D; de Los Santos ELC; Song L; Corre C; Alkhalaf LM; Challis GL
Nucleic Acids Res; 2023 Feb; 51(3):1488-1499. PubMed ID: 36718812
[TBL] [Abstract][Full Text] [Related]
14. Multiplexed metagenome mining using short DNA sequence tags facilitates targeted discovery of epoxyketone proteasome inhibitors.
Owen JG; Charlop-Powers Z; Smith AG; Ternei MA; Calle PY; Reddy BV; Montiel D; Brady SF
Proc Natl Acad Sci U S A; 2015 Apr; 112(14):4221-6. PubMed ID: 25831524
[TBL] [Abstract][Full Text] [Related]
15. High-Resolution Snapshots of Proteasome Inhibitors in Action Revise Inhibition Paradigms and Inspire Next-Generation Inhibitor Design.
Carmony K; Lee W; Kim KB
Chembiochem; 2016 Nov; 17(22):2115-2117. PubMed ID: 27605113
[TBL] [Abstract][Full Text] [Related]
16. Theoretical study of the inhibition mechanism of human 20S proteasome by dihydroeponemycin.
Serrano-Aparicio N; Świderek K; Moliner V
Eur J Med Chem; 2019 Feb; 164():399-407. PubMed ID: 30611981
[TBL] [Abstract][Full Text] [Related]
17. Eponemycin analogues: syntheses and use as probes of angiogenesis.
Sin N; Meng L; Auth H; Crews CM
Bioorg Med Chem; 1998 Aug; 6(8):1209-17. PubMed ID: 9784862
[TBL] [Abstract][Full Text] [Related]
18. Development of Novel Epoxyketone-Based Proteasome Inhibitors as a Strategy To Overcome Cancer Resistance to Carfilzomib and Bortezomib.
Lee MJ; Bhattarai D; Yoo J; Miller Z; Park JE; Lee S; Lee W; Driscoll JJ; Kim KB
J Med Chem; 2019 May; 62(9):4444-4455. PubMed ID: 30964987
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of novel tripeptidyl epoxyketone derivatives constructed from β-amino acid as proteasome inhibitors.
Zhang J; Cao J; Xu L; Zhou Y; Liu T; Li J; Hu Y
Bioorg Med Chem; 2014 Jun; 22(11):2955-65. PubMed ID: 24767818
[TBL] [Abstract][Full Text] [Related]
20. Identification of a new series of amides as non-covalent proteasome inhibitors.
Scarbaci K; Troiano V; Micale N; Ettari R; Tamborini L; Di Giovanni C; Cerchia C; Grasso S; Novellino E; Schirmeister T; Lavecchia A; Zappalà M
Eur J Med Chem; 2014 Apr; 76():1-9. PubMed ID: 24561716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
